Allogeneic stem cell transplantation for metastatic renal cell cancer (RCC)

Marco Bregni, Fabio Ciceri, Jacopo Peccatori

Research output: Contribution to journalArticlepeer-review


A variety of therapeutic options are now available for advanced renal cell cancer, including antiangiogenic and anti-mTOR agents. Allogeneic hematopoietic stem cell transplantation, through its graft-versus-tumor effect, can induce clinical responses and prolonged survival in selected cytokine-refractory patients. However, the still relevant transplant-related mortality due to toxicity and graft-versus-host disease is an obstacle to its widespread use.

Original languageEnglish
Pages (from-to)347-349
Number of pages3
JournalJournal of Cancer
Issue number1
Publication statusPublished - 2011


  • Advanced renal cell cancer
  • Allogeneic hematopoietic stem cell transplantation
  • Graft-versus-tumor

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Allogeneic stem cell transplantation for metastatic renal cell cancer (RCC)'. Together they form a unique fingerprint.

Cite this